User menu

Population pharmacokinetic analysis of tacrolimus in the first year after pediatric liver transplantation

Bibliographic reference Guy-Viterbo, Vanessa ; Scohy, Anaïs ; Verbeeck, Roger-K. ; Reding, Raymond ; Wallemacq, Pierre ; et. al. Population pharmacokinetic analysis of tacrolimus in the first year after pediatric liver transplantation. In: European Journal of Clinical Pharmacology, Vol. 69, no. 8, p. 1533-1542 (2013)
Permanent URL http://hdl.handle.net/2078.1/132777
  1. Flanagan W. Michael, Corthésy Blaise, Bram Richard J., Crabtree Gerald R., Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A, 10.1038/352803a0
  2. Kelly D. A., Current issues in pediatric transplantation, 10.1111/j.1399-3046.2006.00567.x
  3. Staatz Christine E, Tett Susan E, Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation : , 10.2165/00003088-200443100-00001
  4. Naesens M, Kuypers D, Sarwal M (2009) Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 4(2):481–508
  5. Rodríguez-Perálvarez M., Germani G., Darius T., Lerut J., Tsochatzis E., Burroughs A. K., Tacrolimus Trough Levels, Rejection and Renal Impairment in Liver Transplantation: A Systematic Review and Meta-Analysis : Tacrolimus Levels after Liver Transplantation, 10.1111/j.1600-6143.2012.04140.x
  6. DʼANTIGA LORENZO, DHAWAN ANIL, PORTMANN BERNARD, FRANCAVILLA RUGGIERO, RELA MOHAMMED, HEATON NIGEL, MIELI-VERGANI GIORGINA, LATE CELLULAR REJECTION IN PAEDIATRIC LIVER TRANSPLANTATION : AETIOLOGY AND OUTCOME, 10.1097/00007890-200201150-00015
  7. Staatz Christine E., Goodman Lucy K., Tett Susan E., Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I : , 10.2165/11317350-000000000-00000
  8. Willis Charlene, Staatz Christine E., Tett Susan E., Bayesian Forecasting and Prediction of Tacrolimus Concentrations in Pediatric Liver and Adult Renal Transplant Recipients : , 10.1097/00007691-200304000-00004
  9. Yasuhara M, Hashida T, Toraguchi M et al (1995) Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations. Transplant Proc 27(1):1108–1110
  10. Sam W. J., Aw M., Quak S. H., Lim S. M., Charles B. G., Chan S. Y., Ho P. C., Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients : Population pharmacokinetics of tacrolimus, 10.1046/j.1365-2125.2000.00288.x
  11. Sam Wai Johnn, Tham Lai San, Holmes Michael J, Aw Marion, Quak Seng Hock, Lee Kang Hoe, Lim Seng Gee, Prabhakaran Krishnan, Chan Sui Yung, Ho Paul C, Population Pharmacokinetics of Tacrolimus in Whole Blood and Plasma in Asian Liver Transplant Patients : , 10.2165/00003088-200645010-00004
  12. Staatz Christine E., Taylor Paul J., Lynch Stephen V., Willis Charlene, Charles Bruce G., Tett Susan E., POPULATION PHARMACOKINETICS OF TACROLIMUS IN CHILDREN WHO RECEIVE CUT-DOWN OR FULL LIVER TRANSPLANTS : , 10.1097/00007890-200109270-00013
  13. Sanchez Mar??a Jose, Manzanares Cecilia, Santos-Buelga Dolores, Bl??zquez Alberto, Manzanares Javier, Urruzuno Pedro, Medina Enrique, Covariate Effects on the Apparent Clearance of Tacrolimus in Paediatric Liver Transplant Patients Undergoing Conversion Therapy : , 10.2165/00003088-200140010-00005
  14. FUKUDO M, YANO I, MASUDA S, GOTO M, UESUGI M, KATSURA T, OGURA Y, OIKE F, TAKADA Y, EGAWA H, Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients, 10.1016/j.clpt.2006.06.008
  15. Wallin Johan E, Bergstrand Martin, Wilczek Henryk E, Nydert Per S, Karlsson Mats O, Staatz Christine E, Population Pharmacokinetics of Tacrolimus in Pediatric Liver Transplantation: Early Posttransplantation Clearance : , 10.1097/ftd.0b013e31823415cc
  16. de Wildt Saskia N., van Schaik Ron H. N., Soldin Offie P., Soldin Steve J., Brojeni Parvaneh Yazdani, van der Heiden Ilse P., Parshuram Chris, Nulman Irena, Koren Gideon, The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantation, 10.1007/s00228-011-1083-7
  17. Antignac Marie, Hulot Jean Sebastien, Boleslawski Emmanuel, Hannoun Laurent, Touitou Yvan, Farinotti Robert, Lechat Philippe, Urien Saïk, Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance, 10.1007/s00228-005-0933-6
  18. Staatz C, Toward better outcomes with tacrolimus therapy: Population pharmacokinetics and individualized dosage prediction in adult liver transplantation, 10.1053/jlts.2003.50023
  19. Fukatsu S, Yano I, Igarashi T et al (2001) Population pharmacokinetics of tacrolimus in adult recipients receiving living-donor liver transplantation. Eur J Clin Pharmacol 57(6–7):479–484
  20. Zahir Hamim, McLachlan Andrew J, Nelson Ameeta, McCaughan Geof, Gleeson Margaret, Akhlaghi Fatemeh, Population Pharmacokinetic Estimation of Tacrolimus Apparent Clearance in Adult Liver Transplant Recipients : , 10.1097/01.ftd.0000170029.36573.a0
  21. Blanchet B, Duvoux C, Costentin CE et al (2008) Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period. Ther Drug Monit 30(4):412–418
  22. Li D., Lu W., Zhu J.-Y., Gao J., Lou Y.-Q., Zhang G.-L., Population pharmacokinetics of tacrolimus and CYP3A5, MDR1 and IL-10 polymorphisms in adult liver transplant patients : Tacrolimus population pharmacokinetics and CYP3A5, 10.1111/j.1365-2710.2007.00850.x
  23. Oteo Itziar, Lukas John C., Leal Nerea, Suarez Elena, Valdivieso Andres, Gastaca Mikel, Ortiz de Urbina Jorge, Calvo Rosario, Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction, 10.1007/s00228-012-1300-z
  24. Wallemacq Pierre, Armstrong Victor W, Brunet Merce, Haufroid Vincent, Holt David W, Johnston Atholl, Kuypers Dirk, Meur Yannick Le, Marquet Pierre, Oellerich Michael, Thervet Eric, Toenshoff Burkhand, Undre Nas, Weber Lutz T, Westley Ian S, Mourad Michel, Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference : , 10.1097/ftd.0b013e318198d092
  25. Sheiner Lewis B., Beal Stuart L., Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: Routine clinical pharmacokinetic data, 10.1007/bf01061870
  26. Alak Ala M., Measurement of Tacrolimus (FK506) and Its Metabolites : A Review of Assay Development and Application in Therapeutic Drug Monitoring and Pharmacokinetic Studies, 10.1097/00007691-199706000-00016
  27. Wallemacq Pierre, Goffinet Jean-Sebastien, OʼMorchoe Susan, Rosiere Thomas, Maine Gregory T, Labalette Myriam, Aimo Giuseppe, Dickson Diana, Schmidt Ed, Schwinzer Reinhard, Schmid Rainer W, Multi-site Analytical Evaluation of the Abbott ARCHITECT Tacrolimus Assay : , 10.1097/ftd.0b013e31819c6a37
  28. Lindbom Lars, Pihlgren Pontus, Jonsson Niclas, PsN-Toolkit—A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM, 10.1016/j.cmpb.2005.04.005
  29. Bertrand Julie, Comets Emmanuelle, Mentré France, Comparison of Model-Based Tests and Selection Strategies to Detect Genetic Polymorphisms Influencing Pharmacokinetic Parameters, 10.1080/10543400802369012
  30. Hooker Andrew C., Staatz Christine E., Karlsson Mats O., Conditional Weighted Residuals (CWRES): A Model Diagnostic for the FOCE Method, 10.1007/s11095-007-9361-x
  31. Schwartz G. J., Work D. F., Measurement and Estimation of GFR in Children and Adolescents, 10.2215/cjn.01640309
  32. Comets Emmanuelle, Brendel Karl, Mentré France, Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for R, 10.1016/j.cmpb.2007.12.002
  33. Jusko William J., Piekoszewski Wojciech, Klintmalm Goran B., Shaefer Mark S., Hebert Mary F., Piergies Antoni A., Lee Charles C., Schechter Paul, Mekki Qais A., Pharmacokinetics of tacrolimus in liver transplant patients*, 10.1016/0009-9236(95)90153-1
  34. Zhao W, Elie V, Roussey G, Brochard K, Niaudet P, Leroy V, Loirat C, Cochat P, Cloarec S, André J L, Garaix F, Bensman A, Fakhoury M, Jacqz-Aigrain E, Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients, 10.1038/clpt.2009.210
  35. Zhao Wei, Fakhoury May, Baudouin Véronique, Storme Thomas, Maisin Anne, Deschênes Georges, Jacqz-Aigrain Evelyne, Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients, 10.1007/s00228-012-1330-6
  36. Uesugi Miwa, Masuda Satohiro, Katsura Toshiya, Oike Fumitaka, Takada Yasutsugu, Inui Ken-ichi, Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients : , 10.1097/01.fpc.0000184953.31324.e4